We seek to discover and invest in the next transformative public companies in healthcare across the globe. We approach our investments from some simple investing philosophies: High quality management teams developing new technologies and therapies to treat diseases where current standards are subpar and would benefit from the new innovation and therapeutic options.
In particular we seek to invest in those opportunities where we see good proof of concept in the company’s technology and significant upside in valuation based on the company’s future clinical, regulatory, and commercial success. We spend the time to get to understand the technologies and markets the company is pursuing and to get to know the management well to understand their strategic approach to building shareholder value.
Marc is the founder of Vista Point Capital, an investment firm with strategy and business development consulting capabilities, focused on the healthcare sector. In this role he has success as an investor and has helped to secure investment capital, licenses, and partnerships for small life science companies.
Previously he was a partner at Symmetry Capital Management, a life science fund focused on investing in smaller public healthcare companies. He joined Symmetry in 2010 where he co-founded the firm’s Parallax Biomedical Fund. Marc began his investing career at EGM Capital where he founded the firm’s EGM Medical Technology Fund, during which time the fund was consistently a top performer as ranked by Barrons.
He has over 20 years of experience investing in health care companies as well as working with small life sciences companies to help them develop their products, create pharmaceutical development and licensing partnerships, and finance their businesses. In addition, he has negotiated numerous technology licensing agreements. Marc previously served as research analyst at Perceptive Life Sciences, Genesis Merchant Group and as an analyst in the investment-banking group at Cowen & Co. In addition to his work at Vista Point Capital, Mr Pentopoulos is a managing director at Avalon Net Worth, where he holds his broker licenses.
Marc has an MBA from the Wharton School and graduated with honors from UC Berkeley with Bachelor of Arts degrees in Molecular and Cell Biology and Economics. He also is a CFA holder and is proficient in both Spanish and French.